-
-
Call more information
660-596-2224 -
Author: Kelsey Giara, PharmD, RPh MedCentral The US Food and Drug Administration (FDA) is expected to issue a decision on the NDA for suzetrigine on January 30. An oral voltage-gated sodium channel (NaV) inhibitor selective for NaV1.8, suzetrigine was developed to treat moderate-to-severe acute pain. The drug could be the first novel drug class approved […]
Read MoreWe’re excited to announce the formation of a new anesthesia group in Riverdale, GA, located just 10 minutes from the Atlanta Airport. We’re seeking dedicated CRNAs to join our collaborative care team, which will include 4 full-time CRNAs and 2 anesthesiologists managing 4 operating rooms. This is a 25% independent practice and doing own blocks! […]
Read MoreIf you’re an anesthesiologist searching for a balanced lifestyle and rewarding work, you’ll want to check out this opportunity. Our all-anesthesiologist group is seeking a dedicated team member to join our collaborative practice. Position Highlights: Zero Call for 3 Weeks: Enjoy three weeks of no call duty, followed by one week of call. Even during […]
Read MoreAuthors: Singh C S, Mishra N, Pathania S, et al. Cureus 17(1): e77746. doi:10.7759/cureus.77746 January 20, 2025 Abstract Percutaneous nephrolithotomy (PCNL) is an effective, minimally invasive procedure for removing large or complex renal stones. While general anesthesia is commonly used, it may lead to complications such as hemodynamic instability. This procedure typically involves accessing the […]
Read MoreAuthor: Francesca Mathewes Becker’s ASC Review The fate of noncompete agreements has been in flux recently, as the Federal Trade Commission awaits change to leadership and President Donald Trump, while noncompete clauses remain the subject of lawsuits in healthcare. The Economic Innovation Group, a bipartisan public policy organization, has compiled a summary of where noncompetes stand by state. It categorizes each […]
Read More